Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Nuclear Medicine and Biology|April 29, 2014
Evaluation of metabolism, plasma protein binding and other biological parameters after administration of (-)-[(18)F]Flubatine in humansMarianne Patt, Georg A Becker, Udo Grossmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 21, 2016
Feasibility and acceptance of simultaneous amyloid PET/MRILisa Schütz, Donald Lobsien, Dominik Fritzsch, et al.
Journal of Alzheimer'S Disease : JAD|December 17, 2016
Histopathology and Florbetaben PET in Patients Incorrectly Diagnosed with Alzheimer's DiseaseMarwan N Sabbagh, Barbara Schäuble, Keshav Anand, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 16, 2020
(+)-[<sup>18</sup>F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand-results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer's disease and healthy controlsSolveig Tiepolt, Georg-Alexander Becker, Stephan Wilke, et al.
Dementia and Geriatric Cognitive Disorders|April 3, 2009
Early and differential diagnosis of dementia and mild cognitive impairment: design and cohort baseline characteristics of the German Dementia Competence NetworkJohannes Kornhuber, Klaus Schmidtke, Lutz Frolich, et al.
Plos One|July 15, 2014
Memory concerns, memory performance and risk of dementia in patients with mild cognitive impairmentSteffen Wolfsgruber, Michael Wagner, Klaus Schmidtke, et al.
Journal of Alzheimer'S Disease : JAD|July 24, 2009
Measurement of ERK 1/2 in CSF from patients with neuropsychiatric disorders and evidence for the presence of the activated formHans-Wolfgang Klafki, Piotr Lewczuk, Heike Kamrowski-Kruck, et al.
Journal of Alzheimer'S Disease : JAD|August 17, 2013
APOE-dependent phenotypes in subjects with mild cognitive impairment converting to Alzheimer's diseaseKatrin Morgen, Lutz Frölich, Heike Tost, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 12, 2014
Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer's diseaseKatrin Morgen, Alfredo Ramirez, Lutz Frölich, et al.
Journal of Alzheimer'S Disease : JAD|October 21, 2015
The Latent Dementia Phenotype δ is Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive ImpairmentAlexander Koppara, Steffen Wolfsgruber, Luca Kleineidam, et al.
Pageof 6